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Open accThe pathogenicity of Haemoplasma spp. in cats varies with ‘Candidatus Mycoplasma haemominutum’
(CMhm) causing subclinical infection whileMycoplasma haemofelis (Mhf) often induces haemolytic anae-
mia. The aims of this study were to characterise the acute phase response (APR) of the cat to experimental
infection with Mhf or CMhm, and to determine whether chronic feline immunodeﬁciency virus (FIV)
infection inﬂuences this response. The acute phase proteins serum amyloid A (SAA), haptoglobin (Hp)
and a-1-acid glycoprotein (AGP) concentrations were measured pre-infection and every 7–14 days up
to day 100 post-infection (pi) in cats infected with either Mhf or CMhm. Half of each group of cats
(6/12) were chronically and subclinically infected with FIV. Marboﬂoxacin treatment was given on days
16–44 pi to half of the Mhf-infected cats, and on days 49–77 pi to half of the CMhm-infected cats.
FIV-infected animals had signiﬁcantly lower AGP concentrations, and signiﬁcantly greater Hp concen-
trations than non-FIV-infected cats when infected with CMhm and Mhf, respectively. Both CMhm and
Mhf infection were associated with signiﬁcant increases in SAA concentrations, while AGP concentrations
were only signiﬁcantly increased by Mhf infection. Mhf-infected cats had signiﬁcantly greater SAA con-
centrations than CMhm-infected animals. Both Mhf and CMhm infections were associated with an APR,
with Mhf infection inducing a greater response. Chronic FIV infection appeared to modify the APR, which
varied with the infecting Haemoplasma species.
 2012 Published by Elsevier Ltd.Open access under CC BY license.Introduction
Feline haemoplasmas are haemotropic mycoplasmal bacteria.
Mycoplasma haemofelis (Mhf) is themost pathogenic, often inducing
haemolytic anaemia in immunocompetent cats, whilst ‘Candidatus
Mycoplasma haemominutum’ (CMhm) and ‘Candidatus Myco-
plasma turicensis’ do not usually cause anaemia unless concurrent
disease or immunosuppression is present (Tasker et al., 2009;
Tasker, 2010). Subclinical carrier states also exist and the presence
of infection does not conﬁrm that haemoplasmosis is the cause of
the clinical signs (Tasker, 2010).
The acute phase response (APR) is part of the innate immune
response, characterised by changes in serum acute phase protein
(APP) concentrations (Cerón et al., 2005), which can be used as
diagnostic and therapeutic biomarkers (Cerón et al., 2005;
Griebsch et al., 2009; Mitchell et al., 2009). Measurement of APPs
is widely used in human medicine (Berbari et al., 2010; Patel
et al., 2010; Sage et al., 2010), and there is increasing interest in
their use in companion animals (Eckersall, 2010), although thererman).
ess under CC BY license.have to date been limited studies carried out in cats (Harvey and
Gaskin, 1978; Duthie et al., 1997; Kajikawa et al., 1999; Sasaki
et al., 2003; Paltrinieri et al., 2007a,b, 2008; Tamamoto et al.,
2008, 2009). To the authors’ knowledge, the only study evaluating
the APR to haemoplasmosis in cats reported elevated haptoglobin
(Hp) concentrations in six animals experimentally infected with
Mhf (Harvey and Gaskin, 1978).
The aim of the present study was to characterise the APR to
experimental infection with Mhf or CMhm by measuring serum
concentrations of three APPs, serum amyloid A (SAA), haptoglobin
(Hp) and a-1-acid glycoprotein (AGP). The inﬂuence of chronic
feline immunodeﬁciency virus (FIV) infection on the APR to
haemoplasma infection was also assessed.Materials and methods
Study design
This study was performed on serum samples obtained from previous research
(Tasker et al., 2006a,b; Fig. 1). All procedures and experiments described were
undertaken under a project license approved under the UK Animals (Scientiﬁc
Procedures) Act 1986. Brieﬂy, these studies had used 24 speciﬁc pathogen free
(SPF)-derived cats from one of four groups (n = 6 in each case): Groups A and B were
‘Candidatus Mycoplasma haemominutum’
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Fig. 1. Schematic illustration of the experimental design for Groups A, B, X and Y. Protocols are indicated against days post-infection (pi). FIV infection status and mean
packed cell volume (PCV) (dashed lines indicate reference interval) for each group are indicated. Solid arrow, IV inoculation with Haemoplasma spp.; sampling times; shaded
box, marboﬂoxacin administration (identity of treated cats shown).
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arinised blood IV from a CMhm- or Mhf-infected donor cat. Groups A and X were
chronically infected (23–32 months) with FIV (Glasgow8 strain).
All cats were clinically normal at study commencement. Three cats from each
group were randomly selected and given marboﬂoxacin (Marbocyl, Vétoquinol) at
2 mg/kg orally, once daily for 28 days: between days 49–76 post-infection (pi) for
the CMhm-infected cats (cat numbers A2, A4, A5, B2, B3 and B5), and between days
16–43 pi for the Mhf-infected cats (cat numbers X3, X5, X6, Y1, Y5 and Y6) (Tasker
et al., 2006a,b). Differences in the timing of this treatment reﬂected the different
time courses of infection: the Mhf-infected cats were treated early in the course
of infection when anaemia was present, while the CMhm-infected cats, with sub-
clinical infection, were treated later in the course of infection when CMhm copy
numbers remained high.
Each group received the marboﬂoxacin treatment in order to evaluate the re-
sponse of each Haemoplasma spp. All cats were given subcutaneous ﬂuid therapy
(lactated Ringer’s solution) if their PCV fell below 15% and/or the animal exhibited
evidence of dehydration. Serum samples were collected pre-infection (day 0),
weekly between days 9–44 pi (excluding day 30 pi), and then fortnightly until
day 100 pi.
Assays for acute phase proteins
Serum amyloid A concentrations were determined using an immunoturbidi-
metric method used in humans and validated in cats (Hansen et al., 2006).
Alpha-1-acid glycoprotein concentrations were measured using a rapid immuno-
turbidimetric assay validated for use in cats (Bence et al., 2005). Haptoglobin
concentrations were determined using a commercially available kit (Tridelta Devel-
opment Ltd.). The SAA concentration was measured ﬁrst, followed by the AGP and
Hp concentrations, although inadequate amounts of serum were available to ana-
lyse all APPs in all samples: in Group A, seven samples were not analysed for Hp
and three were not analysed for AGP; in Group B, four samples were not assessed
for Hp or AGP; in Group X, ﬁve and two samples were not analysed for Hp and
AGP, respectively; and in Group Y, one sample not examined for Hp or AGP.
Statistical analysis
Data were entered into and validated within a database (Excel 2008, Microsoft),
and then exported into SPSS software (version 18.0) for further analysis. Signiﬁ-
cance was set at P < 0.05. Statistical analysis was only performed on APP concentra-
tions measured pre-treatment to ensure no confounding effects of treatment. To
assess the effect of chronic FIV infection on the APR to haemoplasma infection,
Mann–Whitney U tests were used to compare each APP concentration pi betweenthe FIV-infected and non-FIV-infected animals, for both CMhm and Mhf. To assess
the effect of each infection on the APR, the mean of the APP concentration pi (on
days 9, 16, 23, 37 and 44 for CMhm and on days 9 and 16 for Mhf, respectively)
was compared with pre-infection (day 0) values using aWilcoxon-signed ranks test.
Conventional two-tailed testing was used to assess changes in Hp and AGP
concentrations.
As SAA pre-infection concentrations were below detection limits, the SAA
concentration changes pi were investigated using one-tailed testing. These analyses
were carried out using non-parametric tests due to the small sample sizes. Two-
way repeated measures ANOVA were performed for each APP on days 9–16 pi
(the pre-treatment measurements available for both CMhm and Mhf), using FIV
and Haemoplasma spp. as grouping variables. Residuals from this analysis tested
satisfactorily for normality and homogeneity of variance, conﬁrming the suitability
of this test.Results
Effect of chronic FIV infection on the acute phase response to
haemoplasma infection
Pre-existing FIV infection did not signiﬁcantly affect SAA con-
centrations following CMhm or Mhf infection, Hp concentrations
following CMhm infection, or AGP concentrations following Mhf
infection (Table 1). Therefore, the SAA concentration data for
CMhm-infected (Groups A and B) and Mhf-infected (Groups X
and Y) cats, the Hp data for CMhm-infected (Groups A and B) cats,
and the AGP data for Mhf-infected (Groups X and Y) cats, were
combined for further analyses.
FIV infection did however affect Hp concentrations following
Mhf infection, with FIV-infected cats having signiﬁcantly greater
Hp concentrations than non-FIV-infected animals (Table 1). FIV
infection also affected AGP concentrations following CMhm infec-
tion, with FIV-infected cats having signiﬁcantly lower AGP concen-
trations than non-FIV-infected animals (Table 1). Thus, Hp
concentrations in Mhf-infected cats (Groups X and Y), and AGP
concentrations in CMhm-infected cats (Groups A and B), were
analysed separately.
Table 1
Statistical analysis of data for each infecting Haemoplasma spp. and for each acute phase protein (APP) comparing non-FIV-infected and FIV-infected cats and pre- (day 0) and
post haemoplasma-infection, respectively. Reference intervals are given for each APP. Statistically signiﬁcant results are highlighted in bold, with the median (and range)
measurements for each group. For each APP, where no signiﬁcant difference was found between FIV-infected and non-FIV-infected cats, data were combined for the comparison
of pre- and post-haemoplasma-infection data.
Infecting Haemoplasma
spp.
Serum amyloid A (618.53 mg/L)a Haptoglobin (63.84 g/L) a-1-Acid glycoprotein (60.48 g/L)
FIV vs.
non-FIV
infected
Pre- vs. post-infection FIV vs. non-FIV infected Pre- vs.
post-
infection
FIV vs. non-FIV
infected
Pre- vs. post-infection
‘Candidatus Mycoplasma
haemominutum’
z = 0.480,
P = 0.699
z = 2.982, P < 0.001 z = 0.480, P = 0.699 z = 1.49,
P = 0.151
z = 2.562,
P = 0.009
FIV: z = 1.363,
P = 0.219
Pre-infection 60.38 mg/L
(60.38 mg/L) vs. post-infection
0.83 mg/L (60.38–24.02 mg/L)
FIV 0.08 g/L
(0.03–0.13 g/L) vs.
non-FIV 0.26 g/L
(0.09–0.36 g/L)
Non-FIV: z = 0.943,
P = 0.438
Mycoplasma haemofelis z = 0.480,
P = 0.699
z = 3.059, P < 0.001 z = 2.402, P = 0.015 FIV:
z = 1.782,
P = 0.094
z = 1.761,
P = 0.093
z = 2.197, P = 0.027
Pre-infection 60.38 mg/L
(60.38 mg/L) vs. post-infection
32.2 mg/L (1.45–77 mg/L)
FIV 2.43 g/L (1.05–
3.65 g/L) vs. non-FIV
0.41 g/L (0.15–2.45 g/L)
Non-FIV:
z = 0.105,
P = 1.00
Pre-infection 0.15 g/L
(0–0.75 g/L) vs. post-
infection 0.58 g/L
(0.06–1.46 g/L)
a The lower limit of detection for serum amyloid A was 0.38 mg/L.
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Fig. 2. Graph illustrating alterations in serum amyloid A (SAA) concentrations over
time: (A) following ’Candidatus Mycoplasma haemominutum’ (CMhm) infection of
FIV-infected (Group A, solid line) and non-FIV-infected (Group B, dashed line) cats.
Marboﬂoxacin was given to a proportion of animals (indicated by open markers) on
days 49–77 pi; (B) following Mycoplasma haemofelis (Mhf) infection of FIV-infected
(Group X, solid line) and non-FIV-infected (Group Y, dashed line) cats. Marboﬂox-
acin was given to a proportion of animals (indicated by open markers) on days
16–44 pi. The shaded panels represent the reference interval for SAA concentration
in cats.
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Up to day 44 pi following CMhm infection, 7/12 cats demon-
strated rises in SAA concentration (Fig. 2A), with peak concentra-
tions on days 16 or 23 pi. Mean SAA concentrations were
signiﬁcantly elevated up to day 44 pi compared with day 0 (Table
1), but had returned to baseline levels in all but one of the CMhm-
infected cats by day 44 pi, just prior to the marboﬂoxacin treat-
ment. Serum amyloid A concentrations in this cat (B1) had
returned to baseline levels by day 58 pi. Increased SAA concentra-
tions were detected in 11/12 Mhf-infected cats (Fig. 2B), with con-
centrations peaking around day 9 pi. Mean SAA concentrations
were signiﬁcantly elevated up to day 16 pi compared with day 0
(Table 1).
Marboﬂoxacin treatment was associated with decreased SAA
concentration in some Mhf-infected cats (e.g. X6 and Y6), but in
others (e.g. X5 and Y1) the concentration of this AAP had started
decreasing prior to treatment. A two-way ANOVA did not detect
an interaction effect between FIV and haemoplasma infection on
SAA concentrations (F = 3.122, P = 0.092) up to day 16 pi, however
Mhf-infected cats had signiﬁcantly higher mean SAA concentra-
tions (27.05 ± 0.4 mg/L) compared with CMhm-infected animals
(0.94 ± 0.4 mg/L) (F = 31.706, P < 0.001). FIV infection status did
not have a signiﬁcant effect (F = 0.790, P = 0.385).
Effect of haemoplasma infection on haptoglobin concentration
Variably increased Hp concentrations occurred in 10/12 CMhm-
infected cats up to day 23 pi, but mean concentrations were not
signiﬁcantly different up to day 44 pi compared with day 0 values
(Fig. 3A; Table 1). By the time marboﬂoxacin treatment
commenced on day 49 pi, Hp concentrations were already declin-
ing in 8/12 of the CMhm-infected cats. Mhf-infected animals dem-
onstrated both increased and decreased Hp concentrations from
baseline levels on day 9 pi (Fig. 3B and C). Mean Hp concentrations
were not signiﬁcantly different up to day 16 pi in both non-FIV-
infected and FIV-infected cats compared with day 0 (Table 1),
although a trend for Hp concentrations to decrease following Mhf
infection was observed in FIV-infected cats. Haptoglobin concen-
trations fell from day 16 pi onwards, and by day 23 pi most cats
had concentrations below pre-infection levels. Marboﬂoxacintreatment did not increase this rate of decline. A two-way ANOVA
showed no signiﬁcant: difference in Hp concentrations between
Mhf- and CMhm-infected cats up to day 16 pi (F = 0.745,
P = 0.404); effect of FIV status (F = 3.56, P = 0.082); effect of interac-
tion between these factors (F = 3.178, P = 0.098).
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Fig. 3. Graph illustrating alterations in serum haptoglobin (Hp) concentrations over
time: (A) following ’Candidatus Mycoplasma haemominutum’ (CMhm) infection of
FIV-infected (Group A, solid line) and non-FIV-infected (Group B, dashed line) cats.
Marboﬂoxacin was given to a proportion of animals (indicated by open markers) on
days 49–77 pi; (B) following Mycoplasma haemofelis (Mhf) infection of FIV-infected
cats (Group X, solid line). Marboﬂoxacin was given to a proportion of animals
(indicated by open markers) on days 16–44 pi; (C) following Mhf infection of non-
FIV-infected cats (Group Y, dashed line). Marboﬂoxacin was given to a proportion of
animals (indicated by open markers) on days 16–44 pi. The shaded panels represent
the reference interval for Hp concentration in cats.
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Fig. 4. Graph illustrating alterations in serum a-1-acid glycoprotein (AGP)
concentrations over time: (A) following ‘Candidatus Mycoplasma haemominutum’
(CMhm) infection of FIV-infected cats (Group A, solid line). Marboﬂoxacin was
given to a proportion of animals (open markers) on days 49–77 pi; (B) following
CMhm infection of non-FIV-infected cats (Group B, dashed line). Marboﬂoxacin was
given to a proportion of animals (open markers) on days 49–77 pi; (C) following
Mycoplasma haemofelis (Mhf) infection of FIV-infected (Group X, solid line) and non-
FIV-infected (Group Y, dashed line) cats. Marboﬂoxacin was given to a proportion of
animals (open markers) on days 16–44 pi. The shaded panels represent the
reference interval for AGP concentration in cats.
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Up to day 44 pi, CMhm infection was not associated with signif-
icantly different AGP concentrations in either FIV-infected or non-
FIV-infected cats compared with day 0 values (Fig. 4A and B; Table
1). Small ﬂuctuations in AGP concentration occurred throughout the
study in both treated and untreated CMhm-infected cats, withmost
variation seen in non-FIV-infected cats up to day 23 pi of CMhm
infection. Mhf infection was associated with variable AGP concen-
trations, with varying peaks and ﬂuctuations evident throughout,
and one cat (Y2) developing amarked elevation in the concentration
of this AAP at day 23 pi (Fig. 4C). Signiﬁcantly highermean AGP con-
centrations were recorded up to day 16 pi following Mhf infection
compared with day 0 (Table 1). A two-way ANOVA did not demon-
strate a signiﬁcant difference in AGP concentrations between
Mhf- and CMhm-infected cats up to day 16 pi (F = 3.809, P = 0.07),although signiﬁcance was approached, with Mhf-infected cats
exhibiting larger AGP concentrations (0.368 ± 0.063 g/L) than their
CMhm-infected cohorts (0.170 ± 0.052 g/L). The interaction effect
was modelled, but was not found to be signiﬁcant (F = 1.84,
P = 0.195), although a signiﬁcant effect of FIV status was detected
(F = 14.86, P = 0.002).Discussion
To the authors’ knowledge, this is the ﬁrst study to comprehen-
sively evaluate the APR of cats to infection with Haemoplasma spp.
Given that the serum analysed was obtained during previous stud-
ies investigating haemoplasma/chronic FIV infection (Tasker et al.,
2006a,b), a concurrent systemic viral infection could have had a
confounding effect on our results. A glycan moiety of AGP has been
shown to be modiﬁed in cats subclinically and terminally-infected
with FIV (Pocacqua et al., 2005). In the present study lower AGP
concentrations were found in FIV-infected compared with
R.M. Korman et al. / The Veterinary Journal 193 (2012) 433–438 437non-FIV-infected animals following CMhm infection and higher Hp
concentrations occurred in FIV-infected compared with non-FIV-
infected cats infected with Mhf. However, while these results were
statistically signiﬁcant, measurements for each group of cats
remained within reference intervals and numbers in each group
were small. These results are in contrast to those of Duthie et al.
(1997), where APPs were measured at a single time-point in six
cats with terminal, FIV-associated disease. This study found that
5/6 and 4/6 cats had AGP and Hp concentrations above the refer-
ence intervals, respectively.
Marked increases in AGP have been found during the acute
phase of viral infection with feline coronavirus (Paltrinieri et al.,
2004), although decreases in APPs following viral infection, either
acute or chronic, have not been described. In patients with human
immunodeﬁciency virus (HIV) infection, many APPs (e.g. C-reactive
protein [CRP], Hp, and ﬁbrinogen) are higher compared with
non-HIV-infected controls (Jahoor et al., 1999; Treitinger et al.,
2001; Delanghe et al., 2010). Elevations in the concentration of
APPs, particularly CRP, are associated with increased mortality
and opportunistic disease such as Pneumocystis jirovecii pneumonia
(Nixon and Landay, 2010; Sage et al., 2010) in AIDS patients. CRP is
not part of the feline APR (Cerón et al., 2005) and, to the authors’
knowledge, there are no studies comparing the APR between HIV
and FIV infection. Serum samples taken pre- and immediately
post-FIV infection from the cats in the current study were not
available for analysis, and were beyond the scope of this study.
The raised SAA concentration observed following infection with
both Haemoplasma spp. was evident in most cats by day 16 pi, as
previously described in cats with urinary tract disorders and post-
surgery (Kajikawa et al., 1999; Sasaki et al., 2003). SAA
concentrations usually returned close to pre-infection values by
day 44 pi consistent with a self-limiting APR, and despite sustained
circulating haemoplasma copy numbers (Tasker et al., 2006a,b).
This ﬁnding indicates that an elevated SAA concentration in a hae-
moplasma-infected cat suggests acute (<44 days post-exposure),
rather than chronic, infection. Infection with Mhf was associated
with signiﬁcantly higher SAA concentrations than CMhm infection,
consistent with Mhf being more pathogenic (Foley et al., 1998;
Westfall et al., 2001; Tasker et al., 2006a, 2009). Haematological
variables had been previously assessed in these cats (Tasker
et al., 2006a,b) with 10/12 Mhf-infected cats developing regenera-
tive macrocytic, hypochromic haemolytic anaemia by day 14 pi.
The rapid increases in SAA observed in these animals by day 9
pi, therefore mirrored the development of anaemia. Although
Mhf infection was associated with signiﬁcantly greater SAA
concentrations than infection with CMhm, the latter was also asso-
ciated with signiﬁcant increases in SAA, conﬁrming induction of an
APR by CMhm, albeit of lower magnitude. Indeed, Tasker et al.
(2006a) found that CMhm infection resulted in decreased PCV in
all cats, but in only one-third of animals did this decrease to the
point of anaemia. The concentration of SAA also correlates with
disease severity in feline pancreatitis (Tamamoto et al., 2009),
where decreases mirror clinical improvement. In the current study,
the fact that treatment was not instigated when the APR was max-
imal and/or clinical signs were apparent may explain the lack of
association between SAA concentrations and treatment found.
Haptoglobin concentrations did not change signiﬁcantly follow-
ing either CMhm or Mhf infection, nor was there a signiﬁcant
difference in the concentration of this biomarker between CMhm
and Mhf infections. A trend for Hp concentrations to decrease
following Mhf infection was seen among the FIV-infected cats,
perhaps because circulating Hp complexes with haemoglobin
(Hershko et al., 1973), causing transient decreases in Hp during
haemolysis, as previously reported in experimentally infected cats
(Harvey and Gaskin, 1978). The reason why this was only identiﬁed
in FIV-infected cats remains unknown, and FIV infection was notassociated with more severe haemolysis following intercurrent
Mhf infection (Tasker et al., 2006b).
The concentration of AGP was signiﬁcantly elevated, albeit to a
highly variable degree between individuals, during acute Mhf, but
not during acute CMhm, infection, possibly due to the more path-
ogenic nature of Mhf. Thus, AGP may be a less sensitive indicator of
the feline APR than SAA, since infection with both Mhf and CMhm
was associated with signiﬁcant increases in SAA. It is likely that
particular APPs have different sensitivities in responding to differ-
ent disease processes, as is the case with SAA and C-reactive
protein in humans with kidney allograft rejections (Casl et al.,
1995). Although, to the authors’ knowledge, a comparison of the
sensitivities of SAA and AGP in the feline APR has not been carried
out, SAA increases and peaks earlier than AGP and Hp following
experimentally-induced inﬂammation (Kajikawa et al., 1999).
The retrospective nature of the current study resulted in a num-
ber of limitations: serum sample volumes were not sufﬁcient to
facilitate the analysis of all three APPs in all samples; statistical
power and the elimination of variations in individual responses
was limited by the relatively small number of animals in each
group (this number would have been further reduced if treated
and untreated cats had been compared) and treatment periods
for the Mhf- and CMhm-infected cats were different, which limited
statistical analysis of differences between the two infecting Hae-
moplasma spp. More frequent sampling during acute infection
when the APR is maximal (e.g. daily up to day 30 pi), may have pro-
vided greater statistical power by facilitating daily statistical com-
parisons (Kajikawa et al., 1999). Instead, because there were few
data points recorded within this period, statistical analysis was
performed on the mean APP concentrations pi for each infecting
haemoplasma. Finally, the APR in cats with naturally occurring
FIV and Haemoplasma spp. infection may be different from our
experimentally infected animals. Differences in disease transmis-
sion and/or exposure to other pathogens may be important in this
context.
Although not all data were analysed statistically, the present
study still provides valuable information as to the long-term
changes in APPs following haemoplasma infection and antibiotic
treatment.Conclusions
This study has demonstrated that both Mhf and CMhm, despite
differing pathogenicity, are associated with an APR in infected cats.
Although APPs are non-speciﬁc indicators of inﬂammation and
infection, their measurement may facilitate the differentiation of
acute/clinical from chronic/subclinical haemoplasma infection.
SAA was found to have particular promise in this context by rising
higher followingMhf thanCMhminfection, andby rapidly returning
to baseline levels after the acute phase of infection.Conﬂict of interest statement
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